COMMERCIALIZATION SOLUTIONS FOR THE ORTHOPEDIC INDUSTRY
DECEMBER 2020 | VOLUME 2 | SUBSCRIBE

The global spread of COVID-19 not only exacerbated present challenges but presented new obstacles for orthopedic OEMs in 2020.

Close to 550 orthopedic products received clearances in this hectic year, allowing us to keep this popular monthly 510(k) recap relevant. Here are 10 clearances that I found to be of interest throughout 2020.
Trends in the December Issue:


 A burgeoning set of small orthopedic implant companies is developing devices designed to anticipate and suit individual patients’ unique anatomy.

Conducting successful clinical trials will require orthopedic companies to demonstrate flexibility and adaptability in the future.
Industry Voices in the December Issue:


While 2020 brought unpredictability, it highlighted numerous opportunities for improvement of processes and technologies with digital tools, additive manufacturing and O.R. platforms.

One thing that the pandemic has taught Cheryl Blanchard, Ph.D., Anika's CEO, is the need to stay aware of how quickly and dramatically the world can change.
Popular 2020 Reads


Global sales grew +3.8% to $53 billion in 2019. COVID created much uncertainty for the forecast. We’re planning for a disruption to procedure volumes and day-to-day business to last into 2021.

How do you handle medical device risk management? Staying current with the latest regulations, standards and guidance are keys to unlock those doors.



The December Issue is Online!

Prefer print? Confirm your subscription today and pay $0/year with promo code ENEWS.

Working remote? Place your order and provide your home address.
Popular 2020 Reads


Rule #1 for successful product development is to tie design outputs to user needs. Dale Tempco shares how this step and 8 others helped him decrease product development setbacks throughout his career.

Dozens of startups seek to disrupt the orthopedic atmosphere in the near-term and beyond. We examined five companies from different segments that recently reached the market - or plan to by 2022.

Copyright © 2020. All Rights Reserved.